X3 Clean Spray
NDC Package 26550-002-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

X3 Clean (benzalkonium chloride) sprays is a medication used as Antimicrobial. This formulation utilizes a spray delivery system. Marketed by X3 Labs Inc., this product is identified by NDC 26550-002 and is authorized under FDA application M003.

Identification & Billing

NDC Package Code
26550-002-10
Package Description
8 mL in 1 BOTTLE
Product Code
26550-002
11-Digit Billing Format
26550000210
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
X3 Clean
Non-Proprietary Name
Benzalkonium Chloride
Substance Name
Benzalkonium Chloride
Dosage Form
Spray - A liquid minutely divided as by a jet of air or steam.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
BENZALKONIUM CHLORIDE 1.3 mg/mL
Usage Information
This product is used as Antimicrobial

Regulatory & Marketing

Labeler Name
X3 Labs Inc.
Product Type
Human Otc Drug
FDA Application #
M003
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
09-01-2009
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 26550-002-10 identifies a specific commercial package of 8 ml in 1 bottle of X3 Clean, a human over the counter drug labeled by X3 Labs Inc.. This spray is formulated for topical use and contains benzalkonium chloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by X3 Labs Inc. on September 01, 2009. The current certification is valid through December 31, 2026.

How is this X3 Labs Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 26550000210. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
26550-002-10
11-Digit CMS (5-4-2)
26550-0002-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.